China
· Delayed Price · Currency is CNY Well Lead Medical Statistics
Total Valuation
SHA:603309 has a market cap or net worth of CNY 4.00 billion. The enterprise value is 4.12 billion.
| Market Cap | 4.00B |
| Enterprise Value | 4.12B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jan 8, 2026 |
Share Statistics
SHA:603309 has 291.87 million shares outstanding. The number of shares has decreased by -0.34% in one year.
| Current Share Class | 291.87M |
| Shares Outstanding | 291.87M |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | -1.49% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 12.04% |
| Float | 142.68M |
Valuation Ratios
The trailing PE ratio is 51.67 and the forward PE ratio is 12.70. SHA:603309's PEG ratio is 0.67.
| PE Ratio | 51.67 |
| Forward PE | 12.70 |
| PS Ratio | 2.44 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | 25.12 |
| P/OCF Ratio | 10.44 |
| PEG Ratio | 0.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.15, with an EV/FCF ratio of 25.83.
| EV / Earnings | 53.24 |
| EV / Sales | 2.51 |
| EV / EBITDA | 10.15 |
| EV / EBIT | 13.23 |
| EV / FCF | 25.83 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.83 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 3.49 |
| Interest Coverage | 277.51 |
Financial Efficiency
Return on equity (ROE) is 4.65% and return on invested capital (ROIC) is 11.02%.
| Return on Equity (ROE) | 4.65% |
| Return on Assets (ROA) | 6.97% |
| Return on Invested Capital (ROIC) | 11.02% |
| Return on Capital Employed (ROCE) | 13.67% |
| Weighted Average Cost of Capital (WACC) | 3.30% |
| Revenue Per Employee | 625,476 |
| Profits Per Employee | 29,500 |
| Employee Count | 2,622 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 5.00 |
Taxes
In the past 12 months, SHA:603309 has paid 43.26 million in taxes.
| Income Tax | 43.26M |
| Effective Tax Rate | 32.85% |
Stock Price Statistics
The stock price has increased by +19.83% in the last 52 weeks. The beta is -0.09, so SHA:603309's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +19.83% |
| 50-Day Moving Average | 14.64 |
| 200-Day Moving Average | 14.17 |
| Relative Strength Index (RSI) | 44.59 |
| Average Volume (20 Days) | 6,918,433 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603309 had revenue of CNY 1.64 billion and earned 77.35 million in profits. Earnings per share was 0.27.
| Revenue | 1.64B |
| Gross Profit | 739.60M |
| Operating Income | 311.29M |
| Pretax Income | 131.70M |
| Net Income | 77.35M |
| EBITDA | 397.06M |
| EBIT | 311.29M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 460.04 million in cash and 556.53 million in debt, giving a net cash position of -96.49 million or -0.33 per share.
| Cash & Cash Equivalents | 460.04M |
| Total Debt | 556.53M |
| Net Cash | -96.49M |
| Net Cash Per Share | -0.33 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 6.39 |
| Working Capital | 394.11M |
Cash Flow
In the last 12 months, operating cash flow was 383.53 million and capital expenditures -224.09 million, giving a free cash flow of 159.44 million.
| Operating Cash Flow | 383.53M |
| Capital Expenditures | -224.09M |
| Depreciation & Amortization | 85.77M |
| Net Borrowing | 75.07M |
| Free Cash Flow | 159.44M |
| FCF Per Share | 0.55 |
Margins
Gross margin is 45.10%, with operating and profit margins of 18.98% and 4.72%.
| Gross Margin | 45.10% |
| Operating Margin | 18.98% |
| Pretax Margin | 8.03% |
| Profit Margin | 4.72% |
| EBITDA Margin | 24.21% |
| EBIT Margin | 18.98% |
| FCF Margin | 9.72% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 2.95%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 2.95% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 280.79% |
| Buyback Yield | 0.34% |
| Shareholder Yield | 3.23% |
| Earnings Yield | 1.93% |
| FCF Yield | 3.98% |
Stock Splits
The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 25, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |